Skip to main content

Table 4 Association between TAPSE ≤ 16 mm and risk of cardiac event of patients with HF

From: Liver stiffness for predicting adverse cardiac events in chinese patients with heart failure: a two-year prospective study

 

Univariate

Multivariable

HR

P value

HR

P value

Age (years)

1.00 (0.97–1.03)

0.945

1.01 (0.97–1.05)

0.696

Sex (Male/Female)

0.51 (0.17–1.49)

0.218

0.49 (0.17–1.40)

0.182

Ccr (per 1 ml/min increase)

0.98 (0.97–1.00)

0.004

0.99 (0.97–1.01)

0.424

PLT (per 1 × 109/L increase)

0.99 (0.99–1.00)

0.036

1.00 (0.99–1.01)

0.549

Log2BNP (per 1 increase)

1.35 (1.08–1.70)

0.010

1.15 (0.85–1.55)

0.376

TAPSE ≤ 16 mm

6.82 (2.90–16.01)

 < 0.001

3.31 (1.09–10.07)

0.035

  1. Ccr: creatinine clearance rate; HF: heart failure; LS: liver stiffness; PLT: platelet; TAPSE: tricuspid annual plane systolic excursion;
  2. Log2 (BNP) = 2 based log-transformation of B-type natriuretic peptide
  3. Multivariable Cox analysis model 3 included TAPSE ≤ 16 mm, age, sex, Ccr, log2 (BNP),and platelet
Back to article page

BMC Cardiovascular Disorders

ISSN: 1471-2261

Contact us